TM
ABBV icon

Torren Management’s AbbVie ABBV Stock Holding History

Torren Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3K Hold
45
– – 0.01% 199
2026
Q1 		$9.76K Sell
45
-1,257
-97% -$279K ﹤0.01% 202
2025
Q4 		$298K Buy
+1,302
New +$297K 0.15% 48

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Torren Management's ABBV Position: Q2 2026 in Review

Torren Management held its AbbVie (ABBV) position steady in Q2 2026 at 45 shares worth $11.3K. The position accounts for 0.01% of the portfolio, ranked #199.

Torren Management first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $298K in Q4 2025. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Torren Management held 45 shares of AbbVie worth $11.3K as of Q2 2026.
  • Torren Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.01% of Torren Management's portfolio in Q2 2026, its #199 holding.
  • Torren Management first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Torren Management's AbbVie position peaked at $298K in Q4 2025.
  • 2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.